Livforsakringsbolaget Skandia’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.7M | Buy |
41,040
+11,200
| +38% | +$11.4M | 1.46% | 11 |
|
|
2025
Q4 | $32.1M | Buy |
29,840
+3,334
| +13% | +$3.19M | 1.25% | 12 |
|
|
2025
Q3 | $20.2M | Sell |
26,506
-1,200
| -4% | -$893K | 0.79% | 24 |
|
|
2025
Q2 | $21.6M | Buy |
27,706
+4,200
| +18% | +$3.26M | 0.94% | 18 |
|
|
2025
Q1 | $19.4M | Sell |
23,506
-50
| -0.2% | -$41.6K | 1.1% | 15 |
|
|
2024
Q4 | $18.2M | Sell |
23,556
-5,620
| -19% | -$4.65M | 0.96% | 18 |
|
|
2024
Q3 | $25.8M | Buy |
29,176
+9,994
| +52% | +$8.99M | 1.39% | 9 |
|
|
2024
Q2 | $17.4M | Buy |
19,182
+980
| +5% | +$784K | 1.42% | 9 |
|
|
2024
Q1 | $14.1M | Buy |
18,202
+2,900
| +19% | +$2.06M | 1.2% | 12 |
|
|
2023
Q4 | $8.92M | Buy |
15,302
+537
| +4% | +$313K | 0.85% | 24 |
|
|
2023
Q3 | $7.93M | Sell |
14,765
-650
| -4% | -$335K | 0.87% | 21 |
|
|
2023
Q2 | $7.22M | Sell |
15,415
-1,500
| -9% | -$629K | 0.75% | 32 |
|
|
2023
Q1 | $5.81M | Hold |
16,915
| – | – | 0.61% | 47 |
|
|
2022
Q4 | $6.19M | Sell |
16,915
-10,600
| -39% | -$3.76M | 0.71% | 40 |
|
|
2022
Q3 | $8.9M | Sell |
27,515
-16,440
| -37% | -$5.21M | 1.1% | 14 |
|
|
2022
Q2 | $14.3M | Sell |
43,955
-10,050
| -19% | -$3.02M | 1.24% | 14 |
|
|
2022
Q1 | $15.5M | Hold |
54,005
| – | – | 1.03% | 14 |
|
|
2021
Q4 | $14.9M | Sell |
54,005
-3,500
| -6% | -$887K | 0.95% | 15 |
|
|
2021
Q3 | $13.3M | Sell |
57,505
-2,400
| -4% | -$592K | 0.83% | 23 |
|
|
2021
Q2 | $13.8M | Buy |
59,905
+3,300
| +6% | +$663K | 0.82% | 25 |
|
|
2021
Q1 | $10.6M | Buy |
56,605
+6,900
| +14% | +$1.35M | 0.74% | 28 |
|
|
2020
Q4 | $8.39M | Buy |
49,705
+3,700
| +8% | +$552K | 0.71% | 28 |
|
|
2020
Q3 | $6.81M | Buy |
46,005
+2,340
| +5% | +$362K | 0.73% | 29 |
|
|
2020
Q2 | $7.17M | Buy |
43,665
+7,100
| +19% | +$1.09M | 0.82% | 23 |
|
|
2020
Q1 | $5.07M | Buy |
36,565
+2,600
| +8% | +$357K | 0.71% | 27 |
|
|
2019
Q4 | $4.46M | Sell |
33,965
-3,800
| -10% | -$440K | 0.53% | 45 |
|
|
2019
Q3 | $4.22M | Buy |
37,765
+17,800
| +89% | +$1.98M | 0.5% | 45 |
|
|
2019
Q2 | $2.21M | Buy |
19,965
+10,500
| +111% | +$1.24M | 0.27% | 99 |
|
|
2019
Q1 | $1.23M | Sell |
9,465
-8,952
| -49% | -$1.09M | 0.16% | 135 |
|
|
2018
Q4 | $2.13M | Hold |
18,417
| – | – | 0.32% | 87 |
|
|
2018
Q3 | $1.98M | Sell |
18,417
-10,700
| -37% | -$1.07M | 0.24% | 114 |
|
|
2018
Q2 | $2.48M | Buy |
29,117
+2,400
| +9% | +$197K | 0.23% | 120 |
|
|
2018
Q1 | $2.07M | Hold |
26,717
| – | – | 0.2% | 130 |
|
|
2017
Q4 | $2.26M | Sell |
26,717
-4,700
| -15% | -$400K | 0.22% | 124 |
|
|
2017
Q3 | $2.69M | Sell |
31,417
-4,300
| -12% | -$353K | 0.24% | 116 |
|
|
2017
Q2 | $2.94M | Hold |
35,717
| – | – | 0.27% | 104 |
|
|
2017
Q1 | $3M | Sell |
35,717
-41,300
| -54% | -$3.31M | 0.28% | 100 |
|
|
2016
Q4 | $5.66K | Sell |
77,017
-4,630
| -6% | -$345K | 0.29% | 67 |
|
|
2016
Q3 | $6.6M | Sell |
81,647
-37,670
| -32% | -$3.02M | 0.32% | 61 |
|
|
2016
Q2 | $9.4M | Buy |
119,317
+7,800
| +7% | +$587K | 0.42% | 49 |
|
|
2016
Q1 | $8.03M | Sell |
111,517
-3,600
| -3% | -$272K | 0.38% | 54 |
|
|
2015
Q4 | $9.7M | Buy |
115,117
+8,200
| +8% | +$680K | 0.46% | 50 |
|
|
2015
Q3 | $8.95M | Sell |
106,917
-2,600
| -2% | -$220K | 0.47% | 45 |
|
|
2015
Q2 | $9.14M | Sell |
109,517
-5,030
| -4% | -$383K | 0.45% | 45 |
|
|
2015
Q1 | $8.32M | Sell |
114,547
-4,400
| -4% | -$313K | 0.41% | 50 |
|
|
2014
Q4 | $8.21M | Sell |
118,947
-35,400
| -23% | -$2.39M | 0.38% | 52 |
|
|
2014
Q3 | $10M | Sell |
154,347
-14,500
| -9% | -$918K | 0.38% | 54 |
|
|
2014
Q2 | $10.5M | Hold |
168,847
| – | – | 0.38% | 56 |
|
|
2014
Q1 | $9.94M | Buy |
168,847
+147,847
| +704% | +$8.25M | 0.37% | 56 |
|
|
2013
Q4 | $1.07M | Hold |
21,000
| – | – | 0.69% | 51 |
|
|
2013
Q3 | $1.06M | Hold |
21,000
| – | – | 0.73% | 47 |
|
|
2013
Q2 | $1.03M | Buy |
+21,000
| New | +$1.14M | 0.74% | 38 |
|
Other funds holding LLY
VCM
VPM
Livforsakringsbolaget Skandia's LLY Position: Q1 2026 in Review
Livforsakringsbolaget Skandia increased its Eli Lilly (LLY) stake by 38% in Q1 2026, buying an estimated $11.4M and bringing the position to 41,040 shares worth $37.7M. The position accounts for 1.46% of the portfolio, ranked #11.
Livforsakringsbolaget Skandia first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Livforsakringsbolaget Skandia held 41,040 shares of Eli Lilly worth $37.7M as of Q1 2026.
- Livforsakringsbolaget Skandia bought 11,200 Eli Lilly shares in Q1 2026, an estimated $11.4M.
- Eli Lilly made up 1.46% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #11 holding.
- Livforsakringsbolaget Skandia first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.